Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Older men with lower levels of available testosterone are more likely to be frail.

Testosterone therapy increases bone density in older men with low testosterone levels.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Lespedeza cuneata extract may help treat enlarged prostate.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Finasteride use varies among Denmark, Finland, Norway, and Sweden, with higher usage in Finland and Sweden.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

ESR2 gene variations may be linked to female pattern hair loss.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.